One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2022-163880
Copy DOI Journal: Blood |  Publication Date: Nov 15, 2022 |
 Citations: 1 |
Affiliation: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Zhujiang Hospital, Southern Medical University, Jiangsu T-mab BioPharma (China), Henan Cancer Hospital, Hebei Medical University, Second Hospital of Hebei Medical University, Shanghai Sixth People's Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, Nanfang Hospital, Tianjin Medical University, Tianjin Medical University General Hospital, Jilin University, First Hospital of Jilin University, Huazhong University of Science and Technology, First Affiliated Hospital Zhejiang University, Guangdong Provincial People's Hospital, First Hospital of China Medical University, China Medical University, Peking Union Medical College Hospital, Beijing Tongren Hospital, Shenzhen Second People's HospitalMolecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
